Fundraising Fox
🦊/People
Sign in

Jesper Gromada

Investor

Investor at Third Rock Ventures · Executive Officer at Exonics Therapeutics

Boston, Massachusetts, United States

Find your path to Jesper

351 people in our graph share verified history with Jesper — schools, employers, funds. One of them is your warm intro.

Noubar AfeyanunlockedJesper: together at Laronde (2020–2022)
×11Jesper: together at Third Rock Ventures

About

Jesper Gromada is a Venture Partner at Third Rock Ventures with experience as a pharmaceutical executive and drug discovery scientist. He has led multidisciplinary teams and directed programs across multiple disease areas, with responsibility for the development of more than 10 drug candidates and marketed drugs. His scientific work includes over 150 publications and 30 patent applications, along with established partnerships across academic and biopharmaceutical institutions.

Executive Officer at Exonics Therapeutics

Intro paths

→

In turn, Jesper can intro founders to Exonics Therapeutics's investors below.

Exonics Therapeutics's investors · 1

The Column GroupSan Francisco · $30M checks · since 2017

Experience

  1. Third Rock VenturesVenture Partnercurrent2022 — presentBoston, Massachusetts, United States
  2. LarondeChief Scientific Officer2020 — 2022Cambridge, Massachusetts, United States
  3. Vertex PharmaceuticalsSite Head - Vertex Genetic Therapies2019 — 2020Boston
  4. Exonics TherapeuticsChief Scientific Officer2018 — 2019Greater Boston
  5. Regeneron PharmaceuticalsVP - Muscle and Metabolism Therapeutic Areas2012 — 2018
  6. NovartisExecutive Director2006 — 2012Cambridge, MA
  7. Eli Lilly and CompanyAssociate Director2000 — 2006Hamburg, Germany
  8. Novo NordiskResearch Scientist1995 — 2000Denmark

Skills & more

Diabetes Research3Metabolism Research3Drug Discovery56Metabolic Diseases2Diabetes47Cell Biology23Biopharmaceuticals18Pharmacology17Therapeutics2Pharmaceuticals3Target Identification6Endocrinology7
+8 moreResearchMetabolismProtein ChemistryPharmaceutical IndustryDrug DevelopmentIn VitroCellCell Signaling

Languages Danish · English

From Jesper's professional profile.

Colleagues at Third Rock Ventures

Abbie Celniker
Investor at Third Rock Ventures
Adam Tebbe
Investor at Third Rock Ventures
Alan Ezekowitz
Investor at Third Rock Ventures
Alexis Borisy
General Partner at Third Rock Ventures
Alison Connors
Investor at Third Rock Ventures
Amanda Chan
Investor at Third Rock Ventures
Andrea van Elsas
Investor at Third Rock Ventures
Angelo Severino
Investor at Third Rock Ventures

Frequently asked questions

Who is Jesper Gromada?
Jesper Gromada is a Venture Partner at Third Rock Ventures with experience as a pharmaceutical executive and drug discovery scientist. He has led multidisciplinary teams and directed programs across multiple disease areas, with responsibility for the development of more than 10 drug candidates and marketed drugs. His scientific work includes over 150 publications and 30 patent applications, along with established partnerships across academic and biopharmaceutical institutions.
Where does Jesper Gromada work?
Jesper Gromada is at Third Rock Ventures.
Where did Jesper Gromada go to school?
Jesper Gromada studied at Københavns Universitet - University of Copenhagen (PhD, Cell Biology); Københavns Universitet - University of Copenhagen (DMSci, Physiology).

Same school

Shared employers